Group 1 - First Watch Restaurant Group, Inc. (FWRG) shares have increased by 13.1% over the past four weeks, closing at $17.69, with a mean price target of $22.18 indicating a potential upside of 25.4% [1] - The average of 11 short-term price targets ranges from a low of $17.00 to a high of $25.00, with a standard deviation of $2.18, suggesting variability in analyst estimates [2] - Analysts show a consensus that FWRG will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][11] Group 2 - The Zacks Consensus Estimate for FWRG's current year earnings has increased by 18% over the last 30 days, with no negative revisions [12] - FWRG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [14]

Core Viewpoint - Shares of Priority Technology (PRTH) have increased by 10.1% over the past four weeks, closing at $7.72, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $12.8, representing a 65.8% upside [1] Price Targets - The average price targets from analysts range from a low of $10.00 to a high of $16.00, with a standard deviation of $2.17, indicating variability in estimates [2] - The lowest estimate suggests a 29.5% increase from the current price, while the highest estimate indicates a 107.3% upside [2] Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising earnings estimates higher, which historically correlates with stock price movements, suggesting a potential upside for PRTH [4][11] - Over the last 30 days, one estimate has increased, leading to a 1.9% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank - PRTH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside [13] Caution on Price Targets - While the consensus price target is a useful metric, relying solely on it for investment decisions may not be prudent due to historical inaccuracies in analysts' price targets [3][10]

Group 1 - Aura Minerals (AUGO) shares have increased by 1.7% over the past four weeks, closing at $33.44, with a mean price target of $43.87 indicating a potential upside of 31.2% [1] - The average price targets range from a low of $40.00 to a high of $46.60, with a standard deviation of $3.44, suggesting a relatively high agreement among analysts [2] - Analysts have shown strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 2.5% over the past month, indicating positive sentiment among analysts [12] - AUGO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for potential upside [14]

Core Viewpoint - Delta Air Lines (DAL) shares have increased by 3.6% over the past four weeks, closing at $58.77, with a mean price target of $73.59 indicating a potential upside of 25.2% [1] Price Targets and Analyst Estimates - The mean estimate consists of 20 short-term price targets with a standard deviation of $5.73, where the lowest estimate is $65.00 (10.6% increase) and the highest is $90.00 (53.1% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the price targets, indicating less variability in their estimates [2][9] Analyst Optimism and Earnings Estimates - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [4][11] - The Zacks Consensus Estimate for the current year has risen by 6.5% over the past month, with five estimates increasing and two decreasing [12] Zacks Rank and Investment Potential - DAL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be entirely reliable, the direction they imply can serve as a useful guide for potential price movements [14]

Core Viewpoint - Shares of a.k.a. Brands (AKA) have increased by 40.6% in the past four weeks, closing at $13.81, with a mean price target of $20.5 indicating a potential upside of 48.4% [1] Price Targets - The average price target consists of four estimates ranging from a low of $9.00 to a high of $30.00, with a standard deviation of $11.09, indicating variability among analysts [2] - The lowest estimate suggests a decline of 34.8%, while the highest indicates a potential upside of 117.2% [2] Analyst Consensus and Earnings Estimates - Analysts are optimistic about AKA's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlate with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 4.8%, with one estimate moving higher and no negative revisions [12] Zacks Rank - AKA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to the questionable ability of analysts to set accurate targets [3][10] - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated estimates [8]

Group 1 - Alto Neuroscience, Inc. (ANRO) shares have increased by 162.9% over the past four weeks, closing at $10.2, with a mean price target of $13 indicating a potential upside of 27.5% [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $2.45, where the lowest estimate is $10.00 (2% decline) and the highest is $16.00 (56.9% increase) [2] - Analysts show a consensus that ANRO will report better earnings than previously estimated, which supports the potential for stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for ANRO has increased by 0.5% due to two upward revisions in earnings estimates over the last 30 days, with no negative revisions [12] - ANRO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [14]

Core Viewpoint - Veritone, Inc. (VERI) shows potential for significant upside, with a mean price target of $10.75 indicating an 80.1% increase from the current price of $5.97 [1] Price Targets and Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $9.81, indicating variability among analysts [2] - The lowest estimate is $3.00, suggesting a potential decline of 49.8%, while the highest estimate is $25.00, indicating a potential increase of 318.8% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Consensus - Analysts have shown increasing optimism about VERI's earnings prospects, with a strong consensus in revising EPS estimates higher [11] - Over the last 30 days, one estimate has increased, leading to a 1.4% rise in the Zacks Consensus Estimate [12] - VERI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - CorMedix (CRMD) shows significant upside potential with a mean price target of $20.5, indicating a 68.6% increase from the current price of $12.16 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $2.07, suggesting variability in analyst predictions [2] - The lowest estimate of $17.00 indicates a 39.8% increase, while the highest estimate of $23.00 suggests an 89.1% increase [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about CRMD's earnings prospects, with a positive trend in earnings estimate revisions [11] - Over the last 30 days, three estimates have been revised higher, leading to a 77.4% increase in the Zacks Consensus Estimate [12] - CRMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set accurate targets has been questioned [3][7] - Analysts often set optimistic price targets due to business incentives, which can lead to inflated estimates [8] - While price targets should not be ignored, they should be approached with skepticism [10]

Core Viewpoint - Verastem (VSTM) shows potential for significant upside, with a mean price target of $15.5 indicating a 68.1% increase from the current price of $9.22 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $2.62, suggesting variability in analyst predictions [2] - The lowest estimate of $13.00 indicates a 41% increase, while the highest estimate of $20.00 suggests a potential surge of 116.9% [2] - Analysts' price targets should be approached with caution, as they may not reliably indicate future stock prices [3][7][10] Earnings Estimates and Analyst Agreement - Analysts are optimistic about VSTM's earnings, with a positive trend in earnings estimate revisions indicating potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.4% over the past month, reflecting a positive revision trend [12] - VSTM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While consensus price targets may not be entirely reliable, the direction they imply appears to be a useful guide for potential price movement [14]

Core Viewpoint - Contango ORE, Inc. (CTGO) has seen a 2.1% increase in share price over the past four weeks, closing at $24.5, with analysts suggesting a potential upside of 38.8% based on a mean price target of $34 [1]. Price Targets and Analyst Estimates - The mean estimate for CTGO's price target is $34, with a standard deviation of $1.73, indicating a relatively tight clustering of estimates among analysts [2]. - The lowest price target is $32.00, suggesting a 30.6% increase, while the highest target is $35.00, indicating a 42.9% increase from the current price [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown strong agreement in revising CTGO's earnings estimates upward, which is a positive indicator for potential stock price increases [4][11]. - Over the last 30 days, the Zacks Consensus Estimate for CTGO's current year earnings has increased by 325%, with no negative revisions [12]. - CTGO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, further supporting its potential upside [13]. Conclusion on Price Movement - While the consensus price target may not be entirely reliable, the direction indicated by the price targets and the strong earnings estimate revisions suggest a favorable outlook for CTGO's stock [14].